Breastcancer.org

Breastcancer.org Founded in 2000, Breastcancer.org is the leading online resource for breast cancer and breast health information.

Breastcancer.org is a nonprofit organization dedicated to providing the most reliable, complete, and up-to-date information about breast cancer. One Breastcancer.org visitor shares her thoughts:

Your website became my ‘go to’ place for information every step of the way. I quickly learned that in order to discuss my diagnosis and treatment with my doctors, I had to learn the vocabulary of breast c

ancer. Your website provided me with the crash course I needed to understand what the doctors were telling me and to ask the necessary questions. The website is so well organized and easy to use and offers such a comprehensive range of information. I have recommended your website to other breast cancer patients and will continue to do so. I stay informed on breast cancer issues through your newsletters and your on-line broadcasts. I’d like to thank everyone at breastcancer.org for the work you do in support of breast cancer patients like me.

Here's what we learned about the association between metastatic breast cancer and GLP-1 medicines at 🔗 ⬇️
06/04/2026

Here's what we learned about the association between metastatic breast cancer and GLP-1 medicines at 🔗 ⬇️

New research presented at suggests that bupropion—also known by the brand name Wellbutrin—may help reduce cancer-relat...
06/03/2026

New research presented at suggests that bupropion—also known by the brand name Wellbutrin—may help reduce cancer-related fatigue in women with breast cancer.

Research presented at found a 76% lower risk of recurrence among women with hormone receptor-positive breast cancer wh...
06/03/2026

Research presented at found a 76% lower risk of recurrence among women with hormone receptor-positive breast cancer who most closely followed a lifestyle program that combined:

✅ A low-glycemic Mediterranean diet
✅ 30 minutes of brisk walking daily
✅ Vitamin D supplementation

Researchers also reported improvements in weight, blood sugar control, and metabolic health. However, recurrence rates did not differ significantly between the study’s intervention and control groups overall.

On this podcast episode, global health policy expert and breast cancer survivor Felicia Marie Knaul joins us to discuss ...
06/03/2026

On this podcast episode, global health policy expert and breast cancer survivor Felicia Marie Knaul joins us to discuss why she believes improving cancer care can help create stronger, more equitable health systems around the world.

Managing hot flashes, sleep problems, and sexual side effects can be challenging for many people receiving hormonal ther...
06/03/2026

Managing hot flashes, sleep problems, and sexual side effects can be challenging for many people receiving hormonal therapy for breast cancer.

New results from the OASIS-4 study found that elinzanetant (Lynkuet) helped ease these symptoms regardless of whether women were taking tamoxifen or an aromatase inhibitor, and whether or not they were receiving ovarian suppression.

Gentle Hatha yoga may offer benefits beyond relaxation. A study presented at ASCO 2026 found it helped cancer survivors ...
06/03/2026

Gentle Hatha yoga may offer benefits beyond relaxation. A study presented at ASCO 2026 found it helped cancer survivors manage fatigue, anxiety, and mood disturbances while improving sleep quality. 🧘

Listen to Iain MacPherson, MD, PhD, professor of breast oncology, on this podcast episode from discuss the OPTIMA tria...
06/03/2026

Listen to Iain MacPherson, MD, PhD, professor of breast oncology, on this podcast episode from discuss the OPTIMA trial and how a low Prosigna Risk of Recurrence score may help some people with early-stage HR-positive, HER2-negative breast cancer safely avoid chemotherapy, as well as how he thinks these findings could shape future treatment decisions.

From chemotherapy de-escalation and oral SERDs to metastatic triple-negative breast cancer and GLP-1 medicines, Eleonora...
06/03/2026

From chemotherapy de-escalation and oral SERDs to metastatic triple-negative breast cancer and GLP-1 medicines, Eleonora Teplinsky, MD breaks down some of the biggest breast cancer research updates from , what they could mean for breast cancer care, and the questions researchers are still working to answer.

Final results from the KEYNOTE-522 study confirm that adding Keytruda to chemotherapy before surgery helps people with h...
06/02/2026

Final results from the KEYNOTE-522 study confirm that adding Keytruda to chemotherapy before surgery helps people with high-risk early-stage triple-negative breast cancer live longer and remain cancer-free longer.

Read more: https://bit.ly/ASCO-2026

A review presented at found that BOADICEA may provide more reliable breast cancer risk estimates than some other commo...
06/02/2026

A review presented at found that BOADICEA may provide more reliable breast cancer risk estimates than some other commonly used risk calculators for women with a family history of the disease.

Still, researchers emphasized that while the most common breast cancer risk calculators perform reasonably well, more work is needed before any tool can accurately predict who will and won’t develop breast cancer.

Address

40 E Montgomery Avenue, 4th Floor
Ardmore, PA
19003

Telephone

+16106426550

Website

https://bit.ly/Community-Forums, http://bit.ly/BCOmeetups

Alerts

Be the first to know and let us send you an email when Breastcancer.org posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share